Related references
Note: Only part of the references are listed.A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma
A. J. Zurita et al.
ANNALS OF ONCOLOGY (2012)
Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials
Hai T. Tran et al.
LANCET ONCOLOGY (2012)
Serum leptin: A marker of prostate cancer irrespective of obesity
S. K. Singh et al.
CANCER BIOMARKERS (2010)
Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma
Shahab Uddin et al.
ENDOCRINE-RELATED CANCER (2010)
Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma
Shih-Ping Cheng et al.
SURGERY (2010)
Circulating levels of leptin, adiposity and breast cancer risk
M-H Wu et al.
BRITISH JOURNAL OF CANCER (2009)
The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation
Ha T. T. Phan et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Increasing incidence of thyroid cancer in the United States, 1973-2002
L Davies et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels
Y Miyoshi et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Management and outcome, of recurrent well-differentiated thyroid carcinoma
CE Palme et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2004)
Rapid turnover of the CD8+CD28- T-cell subset of effector cells in the circulation of patients with head and neck cancer
T Tsukishiro et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
Papillary thyroid carcinomas from young adults and children contain a mixture of lymphocytes
J Modi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Impact of previous thyroid autoimmune diseases on prognosis of patients with well-differentiated thyroid cancer
SL Souza et al.
THYROID (2003)
Apoptosis of immune cells in the tumor microenvironment and peripheral circulation of patients with cancer: implications for immunotherapy
TL Whiteside
VACCINE (2002)
Prostate cancer risk and serum levels of insulin and leptin: a population-based study
AW Hsing et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Death receptor ligands, in particular TRAIL, to overcome drug resistance
S de Jong et al.
CANCER AND METASTASIS REVIEWS (2001)
CD95's deadly mission in the immune system
PH Krammer
NATURE (2000)
TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention
M Ahmad et al.
ONCOGENE (2000)